32.54SEK-1.81%Mkt Cap: 1.61B SEKP/E: 24.11Last update: 2026-05-13
Surgical Science Sweden AB (publ) develops and markets virtual reality simulators and customized training solutions for evidence-based medical training in Europe, North and South America, Asia, and internationally. The c…
Industry Peers
Health Information Servicesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)24.11
P/E (Forward)6.48
PEG—
P/B0.38
P/S1.62
EV/EBITDA6.61
EV/Revenue1.06
EPS (TTM)1.31
EPS (Forward)4.87
Cash Flow & Leverage
FCF Yield-13.52%
FCF Margin-21.96%
Operating CF79.80M SEK
CapEx (TTM)49.34M SEK
Net Debt/EBITDA-3.52
Net Debt-560.03M SEK
Technical
SMA 5032.60 (-0.2%)
SMA 20054.34 (-40.1%)
Beta0.57
S&P 52W Chg24.23%
Avg Vol (30d)195.79K
Avg Vol (10d)151.08K
Technical Indicators
RSI (14)46.1
MACD0.1338
MACD Signal0.3744
MACD Hist.-0.2406
BB Upper36.82 SEK
BB Middle34.13 SEK
BB Lower31.43 SEK
BB Width15.78%
ATR (14)1.514 SEK
Vol Ratio (20d)0.34x
52W Range
23.706% of range162.80
52W High162.80 SEK
52W Low23.70 SEK
Profitability
Gross Margin66.28%
EBITDA Margin16.03%
Profit Margin6.73%
Oper. Margin16.64%
ROE1.56%
ROA1.42%
Revenue Growth6.90%
Earnings Growth-8.50%
Balance Sheet
Debt/Equity0.01
Current Ratio4.05
Quick Ratio3.28
Book Value/Sh83.74 SEK
Cash/Share12.08 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split5:1
Split DateMay 25, 2020
Ownership
Shares Out.51.03M
Float37.07M
Insiders30.11%
Institutions41.32%
Analyst Consensus
Rating1.8 (Buy)
Target (Mean)57.40 SEK
Target Range39.00 SEK – 88.00 SEK
# Analysts5
Company
Market Cap1.61B SEK
Enterprise Value1.05B SEK
Revenue (TTM)992.34M SEK
Gross Profit657.68M SEK
Net Income (TTM)66.82M SEK
Revenue/Share19.45 SEK
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees313
Last Price32.54 SEK
CountrySE
SectorHealthcare
IndustryHealth Information Services
ISINSE0014428512